Compare ResMed Inc. (RMD) vs Global X Uranium ETF (URA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs Global X Uranium ETF — how do they compare? ResMed Inc. trades at $196 (market cap $28.81B), while Global X Uranium ETF trades at $40.59. The key difference: ResMed Inc. pays a 1.21% dividend while Global X Uranium ETF pays none. Which is the better fit depends on your goals.
| RMD | URA | |
|---|---|---|
Market Cap | $28.81B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $293.73 | $61.81 |
52-Week Low | $182.82 | $36.45 |
Enterprise Value | $27.99B | — |
Dividend Yield | 1.21% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About Global X Uranium ETF
URA provides broad exposure to the global uranium industry and nuclear energy sector. Unlike pure-play mining funds, it includes companies involved in nuclear component production and infrastructure, with top 2026 holdings such as Cameco, Oklo, and Uranium Energy Corp.
Read more on URA →
